{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T12:52:24Z","timestamp":1756385544404},"reference-count":60,"publisher":"FapUNIFESP (SciELO)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq Bras Endocrinol Metab"],"published-print":{"date-parts":[[2009,10]]},"abstract":"<jats:p>As drogas antiepil\u00e9pticas (DAE) s\u00e3o utilizadas por um enorme contingente de pessoas em todo o mundo - tanto no tratamento das epilepsias como para outros fins - frequentemente por um longo tempo. Por essas raz\u00f5es, torna-se fundamental o conhecimento sobre os potenciais efeitos adversos desses medicamentos, muitos deles envolvendo v\u00e1rios aspectos hormonais e metab\u00f3licos que devem ser do conhecimento do endocrinologista. Nesta revis\u00e3o, foi abordada a rela\u00e7\u00e3o das DAE com anormalidades no metabolismo mineral \u00f3sseo, balan\u00e7o energ\u00e9tico e peso corporal, eixo gonadal e fun\u00e7\u00e3o tireoideana, al\u00e9m de ter sido revisado o papel terap\u00eautico dessas medica\u00e7\u00f5es no tratamento da neuropatia diab\u00e9tica.<\/jats:p>","DOI":"10.1590\/s0004-27302009000700002","type":"journal-article","created":{"date-parts":[[2009,11,27]],"date-time":"2009-11-27T10:23:23Z","timestamp":1259317403000},"page":"795-803","source":"Crossref","is-referenced-by-count":2,"title":["Efeitos end\u00f3crinos e metab\u00f3licos das drogas antiepil\u00e9pticas"],"prefix":"10.1590","volume":"53","author":[{"given":"Luis Gustavo C.","family":"Bortolini","sequence":"first","affiliation":[{"name":"Universidade Federal do Paran\u00e1,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina A. M.","family":"Kulak","sequence":"additional","affiliation":[{"name":"Universidade Federal do Paran\u00e1,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria Z. C.","family":"Borba","sequence":"additional","affiliation":[{"name":"Universidade Federal do Paran\u00e1,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos E.","family":"Silvado","sequence":"additional","affiliation":[{"name":"Universidade Federal do Paran\u00e1"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cesar L.","family":"Boguszewski","sequence":"additional","affiliation":[{"name":"Universidade Federal do Paran\u00e1,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"issue":"suppl. 1","key":"ref1","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1590\/S1676-26492006000200004","article-title":"Hist\u00f3ria do surgimento e desenvolvimento das drogas antiepil\u00e9pticas","volume":"12","author":"Guerreiro CAM","year":"2006","journal-title":"J Epilepsy Clin Neurophysiol."},{"key":"ref2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0074-7742(08)00002-0","article-title":"Epidemiology and classification of epilepsy: gender comparisons","volume":"83","author":"McHugh JC","year":"2008","journal-title":"Int Rev Neurobiol."},{"issue":"5","key":"ref3","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1111\/j.1528-1167.2006.00974.x","article-title":"Prevalence and pattern of epilepsy treatment in different socioeconomic classes in Brazil","volume":"48","author":"Noronha ALA","year":"2007","journal-title":"Epilepsia."},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2165\/00023210-200822010-00003","article-title":"Antiepileptic drugs in non-epilepsy disorders: relations between mechanisms of action and clinical efficacy","volume":"22","author":"Johannessen Landmark C","year":"2008","journal-title":"CNS Drugs."},{"key":"ref5","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0074-7742(06)81006-8","article-title":"Mechanisms of action of antiepileptic drugs","volume":"81","author":"White HS","year":"2007","journal-title":"Int Rev Neurobiol."},{"issue":"4","key":"ref6","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1212\/WNL.63.10_suppl_4.S24","article-title":"Metabolic concerns associated with antiepileptic medications","volume":"63","author":"Sheth RD","year":"2004","journal-title":"Neurology."},{"issue":"1","key":"ref7","first-page":"37","article-title":"Long-term anticonvulsant therapy leads to low bone mineral density-evidence for direct effects of phenytoin and carbamazepine on human osteoblast-like cells","volume":"108","author":"Feldkamp J","year":"2000","journal-title":"Exp Clin Endocrinol Diabetes."},{"issue":"8","key":"ref8","first-page":"2347","article-title":"Phenytoin increases markers of osteogenesis for the human species in vitro and in vivo","volume":"80","author":"Lau KH","year":"1995","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"ref9","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0889-8529(05)70153-5","article-title":"Vitamin D deficiency and disorders of vitamin D metabolism","volume":"29","author":"Thomas MK","year":"2000","journal-title":"Endocrinology and Metabolism Clinics of North America."},{"issue":"5","key":"ref10","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1001\/archneur.59.5.781","article-title":"Antiepileptic drug-induced bone loss in young male patients who have seizures","volume":"59","author":"Andress DL","year":"2002","journal-title":"Archives of Neurology."},{"issue":"6","key":"ref11","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1210\/jcem-58-6-1003","article-title":"Decreased serum ionized calcium and normal vitamin D metabolite levels with anticonvulsant drug treatment","volume":"58","author":"Weinstein RS","year":"1984","journal-title":"J Clin Endocrinol Metab."},{"issue":"9","key":"ref12","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1212\/WNL.58.9.1348","article-title":"Effect of antiepileptic drugs on bone density in ambulatory patients","volume":"58","author":"Farhat G","year":"2002","journal-title":"Neurology."},{"issue":"4","key":"ref13","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1590\/S0004-282X2004000600003","article-title":"Bone mineral density and serum levels of 25 OH vitamin D in chronic users of antiepileptic drugs","volume":"62","author":"Kulak CA","year":"2004","journal-title":"Arq Neuropsiquiatr."},{"issue":"3","key":"ref14","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1590\/S0004-27302007000300016","article-title":"Bone density and bone turnover markers in patients with epilepsy on chronic antiepileptic drug therapy","volume":"51","author":"Kulak CA","year":"2007","journal-title":"Arq Bras Endocrinol Metab."},{"issue":"2","key":"ref15","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0020-1383(95)00189-1","article-title":"Incidence of five common fracture types in an institutional epileptic population","volume":"27","author":"Desai KB","year":"1996","journal-title":"Injury."},{"issue":"11","key":"ref16","doi-asserted-by":"crossref","first-page":"781","DOI":"10.2165\/00023210-200317110-00002","article-title":"Effect of antiepileptic drugs on bodyweight: overview and clinical implications for the treatment of epilepsy","volume":"17","author":"Biton V","year":"2003","journal-title":"CNS Drugs."},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eplepsyres.2007.04.001","article-title":"Leptin and insulin homeostasis in epilepsy: Relation to weight adverse conditions","volume":"75","author":"Hamed SA","year":"2007","journal-title":"Epilepsy Research."},{"issue":"5","key":"ref18","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1046\/j.1528-1157.2002.31501.x","article-title":"Serum insulin and leptin levels in valproate-associated obesity","volume":"43","author":"Pylv\u00e4nen V","year":"2002","journal-title":"Epilepsia."},{"issue":"4","key":"ref19","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1177\/088307380201700405","article-title":"Insulin resistance in epileptic girls who gain weight after therapy with valproic acid","volume":"17","author":"Verrotti A","year":"2002","journal-title":"J Child Neurol."},{"issue":"1-2","key":"ref20","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0920-1211(03)00091-3","article-title":"Valproic acid modulates islet cell insulin secretion: a possible mechanism of weight gain in epilepsy patients","volume":"55","author":"Luef GJ","year":"2003","journal-title":"Epilepsy Research."},{"issue":"2","key":"ref21","doi-asserted-by":"crossref","first-page":"5493","DOI":"10.1210\/en.2004-0877","article-title":"Valproic acid inhibits leptin secretion and reduces leptin messenger ribonucleic acid levels in adipocytes","volume":"145","author":"Lagace DC","year":"2004","journal-title":"Endocrinology."},{"issue":"1","key":"ref22","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S1071-9091(97)80003-4","article-title":"Felbamate","volume":"4","author":"Bourgeois BF","year":"1997","journal-title":"Semin Pediatr Neurol."},{"issue":"4","key":"ref23","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/oby.2003.78","article-title":"Predictors of weight loss in adults with topiramate-treated epilepsy","volume":"11","author":"Ben-Menachem E","year":"2003","journal-title":"Obese Res."},{"issue":"10","key":"ref24","doi-asserted-by":"crossref","first-page":"629","DOI":"10.2165\/00023210-200418100-00002","article-title":"Psychotropic drugs in the treatment of obesity: what promise?","volume":"18","author":"Appolinario JC","year":"2004","journal-title":"CNS Drugs."},{"issue":"14","key":"ref25","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1001\/jama.289.14.1820","article-title":"Zonisamide for weight loss in obese adults: a randomized controlled trial","volume":"289","author":"Gadde KM","year":"2003","journal-title":"JAMA."},{"issue":"8","key":"ref26","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.4088\/JCP.v68n0809","article-title":"Combination therapy of zonisamide and bupropion for weight reduction in obese women: a preliminary, randomized, open-label study","volume":"68","author":"Gadde KM","year":"2007","journal-title":"J Clin Psychiatry."},{"issue":"12","key":"ref27","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1111\/j.1528-1167.2006.00851.x","article-title":"Sexual dysfunctions and blood hormonal profile in men with focal epilepsy","volume":"47","author":"Kuba R","year":"2006","journal-title":"Epilepsia."},{"issue":"2","key":"ref28","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1212\/01.WNL.0000098936.46730.64","article-title":"Effect of epilepsy and antiepileptic drugs on male reproductive health","volume":"62","author":"Isoj\u00e4rvi JI","year":"2004","journal-title":"Neurology."},{"issue":"10","key":"ref29","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1111\/j.1528-1157.1999.tb02012.x","article-title":"The effect of menopause and perimenopause on the course of epilepsy","volume":"40","author":"Harden CL","year":"1999","journal-title":"Epilepsia."},{"issue":"6","key":"ref30","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/j.1528-1167.2005.00705.x","article-title":"Anticonvulsant activity of androsterone and etiocholanolone","volume":"46","author":"Kaminski RM","year":"2005","journal-title":"Epilepsia."},{"issue":"1","key":"ref31","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1177\/1073858406295827","article-title":"Estrogens and epilepsy: why we are so excited?","volume":"13","author":"Veliskova J.","year":"2007","journal-title":"Neuroscientist."},{"issue":"1-3","key":"ref32","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0014-2999(00)00554-9","article-title":"Modulatory actions of steroid hormones and neuropeptides on electrical activity in brain","volume":"405","author":"Jo\u00ebls M","year":"2000","journal-title":"Eur J Pharmacol."},{"issue":"6","key":"ref33","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1111\/j.1460-9568.2005.04338.x","article-title":"The anti-epileptic actions of neuropeptide Y in the hippocampus are mediated by Y2 and not Y5 receptors","volume":"22","author":"El Bahh B","year":"2005","journal-title":"Eur J Neurosci."},{"issue":"Suppl 2","key":"ref34","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.yebeh.2005.08.026","article-title":"3rd. Reproductive and sexual dysfunction in men with epilepsy","volume":"7","author":"Montouris G","year":"2005","journal-title":"Epilepsy Behav."},{"issue":"6","key":"ref35","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1111\/j.1365-2125.1990.tb05457.x","article-title":"The interaction of phenytoin and carbamazepine with combined oral contraceptive steroids","volume":"30","author":"Crawford P","year":"1990","journal-title":"Br J Clin Pharmacol."},{"issue":"19","key":"ref36","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJM199311043291904","article-title":"Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy","volume":"329","author":"Isoj\u00e4rvi JI","year":"1993","journal-title":"N Engl J Med."},{"issue":"4","key":"ref37","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0002-9343(01)00806-3","article-title":"Altered ovarian function and cardiovascular risk factors in valproate-treated women","volume":"111","author":"Isoj\u00e4rvi JI","year":"2001","journal-title":"Am J Med."},{"issue":"4","key":"ref38","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/ana.410430406","article-title":"Valproate, lamotrigine, and insulin-mediated risks in women with epilepsy","volume":"43","author":"Isoj\u00e4rvi JI","year":"1998","journal-title":"Ann Neurol."},{"issue":"7","key":"ref39","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1210\/jcem.86.7.7633","article-title":"Characterization of the reproductive endocrine disorders in women with epilepsy","volume":"86","author":"Bilo L","year":"2001","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"ref40","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1210\/en.2003-0940","article-title":"Valproate potentiates androgen biosynthesis in human ovarian theca cells","volume":"145","author":"Nelson-DeGrave VL","year":"2004","journal-title":"Endocrinology."},{"issue":"1","key":"ref41","first-page":"52","article-title":"Effects of valproate, phenobarbital, and carbamazepine on sex steroid setup in women with epilepsy","volume":"21","author":"Murialdo G","year":"1998","journal-title":"Clin Neuropharmacol."},{"issue":"7","key":"ref42","first-page":"2946","article-title":"Polycystic ovarian syndrome: relationship to epilepsy and antiepileptic drug therapy","volume":"86","author":"Joffe H","year":"2001","journal-title":"J Clin Endocrinol Metab."},{"issue":"12","key":"ref43","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s00228-005-0056-0","article-title":"Alteration of thyroid hormone homeostasis by antiepileptic drugs in humans: involvement of glucuronosyltransferase induction","volume":"61","author":"Benedetti MS","year":"2005","journal-title":"Eur J Clin Pharmacol."},{"issue":"19","key":"ref44","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1001\/jama.1996.03530430039036","article-title":"Normal serum free thyroid hormone concentrations in patients treated with phenytoin or carbamazepine: a paradox resolved","volume":"275","author":"Surks MI","year":"1996","journal-title":"JAMA."},{"issue":"7","key":"ref45","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1046\/j.1528-1157.2001.042007930.x","article-title":"Thyroid function in men taking carbamazepine, oxcarbazepine, or valproate for epilepsy","volume":"42","author":"Isoj\u00e4rvi JI","year":"2001","journal-title":"Epilepsia."},{"issue":"3","key":"ref46","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.0013-9580.2004.26003.x","article-title":"Thyroid function in girls with epilepsy with carbamazepine, oxcarbazepine, or valproate monotherapy and after withdrawal of medication","volume":"45","author":"Vainionp\u00e4\u00e4 LK","year":"2004","journal-title":"Epilepsia."},{"issue":"2","key":"ref47","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jpeds.2007.02.046","article-title":"Risk factors for development of subclinical hypothyroidism during valproic acid therapy","volume":"151","author":"Mikati MA","year":"2007","journal-title":"J Pediatr."},{"issue":"6","key":"ref48","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1111\/j.1442-200X.2007.02456.x","article-title":"Thyroid function and volume in epileptic children using carbamazepine, oxcarbazepine and valproate","volume":"49","author":"Hirfanoglu T","year":"2007","journal-title":"Pediatr Int."},{"issue":"1","key":"ref49","first-page":"97","article-title":"Induction of differentiation and suppression of malignant phenotype of human neuroblastoma BE (2)-C cells by valproic acid: enhancement by combination with interferon a","volume":"20","author":"Cinatl J Jr","year":"2002","journal-title":"Intern J Oncol."},{"issue":"3","key":"ref50","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1210\/jc.2004-1355","article-title":"Valproic acid induces apoptosis and cell cycle arrest in poorly differentiated thyroid cancer cells","volume":"90","author":"Catalano MG","year":"2005","journal-title":"J Clin Endocrinol Metab."},{"key":"ref51","doi-asserted-by":"crossref","first-page":"4936","DOI":"10.1210\/jc.2004-2376","article-title":"Use of antiepileptic drugs in the treatment of chronic painful diabetic neuropathy","volume":"90","author":"Vinik A","year":"2005","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"ref52","doi-asserted-by":"crossref","first-page":"569","DOI":"10.2165\/00003495-200767040-00006","article-title":"Diabetic painful neuropathy: current and future treatment options","volume":"67","author":"Chong MS","year":"2007","journal-title":"Drugs."},{"issue":"3","key":"ref53","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/AJP.0b013e31802fc14a","article-title":"Patient compliance with SSRIs and gabapentin in painful diabetic neuropathy","volume":"23","author":"Giannopoulos S","year":"2007","journal-title":"Clin J Pain."},{"issue":"13","key":"ref54","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1056\/NEJMoa042580","article-title":"Morphine, gabapentin, or their combination for neuropathic pain","volume":"352","author":"Gilron I","year":"2005","journal-title":"N Engl J Med."},{"issue":"Suppl 2","key":"ref55","doi-asserted-by":"crossref","first-page":"S128","DOI":"10.1016\/j.euroneuro.2006.04.005","article-title":"Pregabalin: from molecule to medicine","volume":"16","author":"Kavoussi R","year":"2006","journal-title":"Eur Neuropsychopharmacol."},{"issue":"4","key":"ref56","doi-asserted-by":"crossref","first-page":"956","DOI":"10.2337\/diacare.28.4.956","article-title":"Diabetic neuropathies: a statement by the American Diabetes Association","volume":"28","author":"Boulton AJ","year":"2005","journal-title":"Diabetes Care."},{"issue":"1-2","key":"ref57","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.pain.2006.09.040","article-title":"Lamotrigine for treatment of pain associated with diabetic neuropathy: results of two randomized, double-blind, placebo-controlled studies","volume":"128","author":"Vinik AI","year":"2007","journal-title":"Pain."},{"issue":"9","key":"ref58","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1542\/pir.24-9-317","article-title":"Question from the clinician: adolescent gynecomastia","volume":"24","author":"Rosen DS","year":"2003","journal-title":"Pediat Rev."},{"issue":"9","key":"ref59","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1345\/aph.1D610","article-title":"Nonestrogen treatment modalities for vasomotor symtoms associated with menopause","volume":"38","author":"Fugate SE","year":"2004","journal-title":"Ann Pharmacother."},{"issue":"7","key":"ref60","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1515\/JPEM.2005.18.7.631","article-title":"Current perspective on the pathogenesis of central diabetes insipidus","volume":"18","author":"Ghirardello S","year":"2005","journal-title":"J Pediatr Endocrinol Metab."}],"container-title":["Arquivos Brasileiros de Endocrinologia &amp; Metabologia"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/abem\/v53n7\/02.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,26]],"date-time":"2017-05-26T08:21:05Z","timestamp":1495786865000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0004-27302009000700002&lng=pt&tlng=pt"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":60,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["S0004-27302009000700002"],"URL":"https:\/\/doi.org\/10.1590\/s0004-27302009000700002","relation":{},"ISSN":["0004-2730"],"issn-type":[{"value":"0004-2730","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}